Anne Sîrvent

3.2k total citations
55 papers, 1.1k citations indexed

About

Anne Sîrvent is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Immunology. According to data from OpenAlex, Anne Sîrvent has authored 55 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Hematology, 13 papers in Public Health, Environmental and Occupational Health and 11 papers in Immunology. Recurrent topics in Anne Sîrvent's work include Hematopoietic Stem Cell Transplantation (33 papers), Acute Myeloid Leukemia Research (16 papers) and Acute Lymphoblastic Leukemia research (13 papers). Anne Sîrvent is often cited by papers focused on Hematopoietic Stem Cell Transplantation (33 papers), Acute Myeloid Leukemia Research (16 papers) and Acute Lymphoblastic Leukemia research (13 papers). Anne Sîrvent collaborates with scholars based in France, United States and Italy. Anne Sîrvent's co-authors include Éliane Gluckman, Guillermo Sanz, William Arcese, Vanderson Rocha, Annalisa Ruggeri, Robert J. Soiffer, Nelson J. Chao, John E. Wagner, David I. Marks and Mei‐Jie Zhang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and The Lancet Oncology.

In The Last Decade

Anne Sîrvent

47 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anne Sîrvent France 16 742 385 231 227 176 55 1.1k
Afonso Celso Vigorito Brazil 16 552 0.7× 244 0.6× 125 0.5× 182 0.8× 114 0.6× 54 847
G. B. Vogelsang United States 17 963 1.3× 405 1.1× 186 0.8× 267 1.2× 160 0.9× 28 1.2k
Yamin Tan China 18 580 0.8× 332 0.9× 133 0.6× 165 0.7× 152 0.9× 83 971
Hanyun Ren China 16 618 0.8× 272 0.7× 131 0.6× 329 1.4× 153 0.9× 114 1.1k
Ken Ishiyama Japan 17 555 0.7× 266 0.7× 136 0.6× 186 0.8× 115 0.7× 100 865
Shigeyoshi Makino Japan 16 521 0.7× 259 0.7× 175 0.8× 199 0.9× 73 0.4× 106 936
J. Hows United Kingdom 20 992 1.3× 234 0.6× 413 1.8× 386 1.7× 116 0.7× 40 1.4k
Pietro Sodani Italy 20 870 1.2× 166 0.4× 833 3.6× 153 0.7× 149 0.8× 43 1.4k
Seiko Kato Japan 14 420 0.6× 142 0.4× 76 0.3× 127 0.6× 76 0.4× 80 691
Guillermo Ortí Spain 12 364 0.5× 270 0.7× 68 0.3× 226 1.0× 78 0.4× 32 849

Countries citing papers authored by Anne Sîrvent

Since Specialization
Citations

This map shows the geographic impact of Anne Sîrvent's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne Sîrvent with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne Sîrvent more than expected).

Fields of papers citing papers by Anne Sîrvent

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne Sîrvent. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne Sîrvent. The network helps show where Anne Sîrvent may publish in the future.

Co-authorship network of co-authors of Anne Sîrvent

This figure shows the co-authorship network connecting the top 25 collaborators of Anne Sîrvent. A scholar is included among the top collaborators of Anne Sîrvent based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne Sîrvent. Anne Sîrvent is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kałwak, Krzysztof, Annalisa Ruggeri, Isabel Sánchez‐Ortega, et al.. (2025). Excellent Outcomes in Patients Receiving Tisagenlecleucel for R/R B-Cell ALL: Results from the European Post-Authorization Safety Study (PASS), on Behalf of the Ctiwp, PDWP and ALWP of the EBMT.. Transplantation and Cellular Therapy. 31(2). S218–S218.
2.
3.
Fatobene, Giancarlo, Fernanda Volt, Frederico Rafael Moreira, et al.. (2023). Impact of allele-level HLA matching on outcomes after double cord blood transplantation in adults with malignancies. Blood Advances. 7(13). 3297–3306. 3 indexed citations
4.
Saultier, Paul, Gérard Michel, Anne Sîrvent, et al.. (2023). Chronic Graft-Versus-Host Disease in Long-Term Survivors of Childhood Leukemia. Blood. 142(Supplement 1). 3762–3762. 1 indexed citations
5.
Gavotto, Arthur, Martina Avesani, Hélèna Huguet, et al.. (2023). Impaired aerobic capacity in adolescents and young adults after treatment for cancer or non-malignant haematological disease. Pediatric Research. 94(2). 626–631. 4 indexed citations
6.
7.
8.
Petit, Arnaud, Yves Bertrand, Claire Pluchart, et al.. (2021). Therapeutic approach and outcome of children with Philadelphia chromosome‐positive acute lymphoblastic leukemia at first relapse in the era of tyrosine kinase inhibitors: An SFCE retrospective study. Pediatric Blood & Cancer. 69(2). e29441–e29441. 2 indexed citations
9.
Lamure, Sylvain, Anne-Laure Gagez, Jérémy Delage, et al.. (2020). A Retrospective Comparison of DLI and gDLI for Post-Transplant Treatment. Journal of Clinical Medicine. 9(7). 2204–2204. 8 indexed citations
10.
Neven, Bénédicte, Jean‐Hugues Dalle, Claire Galambrun, et al.. (2020). Ruxolitinib in children with steroid‐refractory acute graft‐versus‐host disease: A retrospective multicenter study of the pediatric group of SFGM‐TC. Pediatric Blood & Cancer. 67(9). e28233–e28233. 14 indexed citations
11.
Prata, Pedro Henrique, Matthieu Resche‐Rigon, Didier Blaise, et al.. (2019). Outcomes of Salvage Haploidentical Transplant with Post-Transplant Cyclophosphamide for Rescuing Graft Failure Patients: a Report on Behalf of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy. Biology of Blood and Marrow Transplantation. 25(9). 1798–1802. 17 indexed citations
12.
Sîrvent, Anne, et al.. (2018). A novel dermo-cosmetic product containing thermal spring water, sucralfate, copper sulfate, and zinc sulfate in the management of hand eczema. Clinical Cosmetic and Investigational Dermatology. Volume 11. 373–381. 9 indexed citations
13.
Bruno, Bénedicte, Eva de Berranger, D. Guimber, et al.. (2017). Better early outcome with enteral rather than parenteral nutrition in children undergoing MAC allo-SCT. Clinical Nutrition. 37(6). 2113–2121. 39 indexed citations
14.
Chevallier, Patrice, Éric Hermet, Mauricette Michallet, et al.. (2016). Évaluation et prise en charge de la surcharge en fer post-greffe : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC). Bulletin du Cancer. 103(11). S255–S266. 3 indexed citations
15.
Fontbrune, Flore Sicre de, Claire Galambrun, Anne Sîrvent, et al.. (2015). Use of Eculizumab in Patients With Allogeneic Stem Cell Transplant-Associated Thrombotic Microangiopathy. Transplantation. 99(9). 1953–1959. 102 indexed citations
16.
Blaise, Didier, Jean‐Marie Boher, Agnès Boyer-Chammard, et al.. (2014). Low non-relapse mortality and long-term preserved quality of life in older patients undergoing matched related donor allogeneic stem cell transplantation: a prospective multicenter phase II trial. Haematologica. 100(2). 269–274. 18 indexed citations
17.
Berranger, Eva de, Gérard Michel, Virginie Gandemer, et al.. (2014). Prise en charge des séquelles après greffe de cellules souches hématopoïétiques chez l’enfant : recommandations de la SFGM-TC. Pathologie Biologie. 62(4). 212–217. 3 indexed citations
18.
Cluzeau, Thomas, Nicolas Mounier, Lionel Mannone, et al.. (2011). New sequential treatment with chemotherapy and reduced‐intensity conditioning for allogeneic stem‐cell transplantation in very high‐risk acute myeloid leukemia. American Journal of Hematology. 86(7). 619–621. 3 indexed citations
19.
Eapen, Mary, Vanderson Rocha, Guillermo Sanz, et al.. (2010). Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis. The Lancet Oncology. 11(7). 653–660. 397 indexed citations
20.
Frelin, Catherine, Pascal Colosetti, Anne Sîrvent, et al.. (2009). NF‐κB inhibition triggers death of imatinib‐sensitive and imatinib‐resistant chronic myeloid leukemia cells including T315I Bcr‐Abl mutants. International Journal of Cancer. 125(2). 308–317. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Afonso Celso Vigorito Breakdown of academic impact, for papers by G. B. Vogelsang Breakdown of academic impact, for papers by Yamin Tan Breakdown of academic impact, for papers by Hanyun Ren Breakdown of academic impact, for papers by Ken Ishiyama Breakdown of academic impact, for papers by Shigeyoshi Makino Breakdown of academic impact, for papers by J. Hows Breakdown of academic impact, for papers by Pietro Sodani Breakdown of academic impact, for papers by Seiko Kato Breakdown of academic impact, for papers by Guillermo Ortí
Rankless by CCL
2026